TRUEN Co., Ltd. (KOSDAQ:417790)

Silk Road Medical Income Statement

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Operating Revenue	54,256	53,601	47,175	38,832	35,980	33,011
Other Revenue	-	-	-	-0	-	-
Revenue	54,256	53,601	47,175	38,832	35,980	33,011
Revenue Growth (YoY)	11.58%	13.62%	21.49%	7.92%	9.00%	15.68%
Cost of Revenue	27,797	27,687	26,298	21,577	18,823	17,646
Gross Profit	26,459	25,914	20,877	17,255	17,157	15,365
Selling, General & Admin	6,731	6,537	6,492	5,132	4,334	3,430
Research & Development	3,318	3,260	2,563	2,679	2,470	2,523
Other Operating Expenses	280.75	203.85	191.85	232.18	370.24	87.69
Operating Expenses	10,818	10,457	9,489	8,246	7,337	6,122
Operating Income	15,642	15,457	11,388	9,009	9,820	9,243
Interest Expense	-6.69	-8.09	-14.49	-11.58	-6.43	-6.88
Interest & Investment Income	1,551	1,574	1,449	642	350.7	221.93
Currency Exchange Gain (Loss)	-26.42	-51.1	-5.28	24.55	14.58	68.97
Other Non Operating Income (Expenses)	12.97	7.23	-22.9	-277.3	-72.48	7.2
EBT Excluding Unusual Items	17,172	16,979	12,794	9,387	10,106	9,534
Gain (Loss) on Sale of Investments	519.15	498.71	707.72	71.49	34.23	55.5
Gain (Loss) on Sale of Assets	27.71	49.46	19.96	-10.19	30.5	-0.64
Asset Writedown	-4.14	-	-27.77	-558.69	-103.87	-60.02
Pretax Income	17,715	17,527	13,494	8,890	10,067	9,529
Income Tax Expense	3,194	3,160	2,530	1,256	1,547	1,451
Net Income	14,521	14,367	10,964	7,633	8,520	8,078
Net Income to Common	14,521	14,367	10,964	7,633	8,520	8,078
Net Income Growth	29.36%	31.04%	43.63%	-10.40%	5.47%	9.78%
Shares Outstanding (Basic)	10	11	10	8	8	0
Shares Outstanding (Diluted)	10	11	10	9	8	0
Shares Change (YoY)	-0.73%	4.78%	16.01%	2.70%	4901.45%	-
EPS (Basic)	1383.31	1365.62	1092.00	906.00	1011.00	47944.01
EPS (Diluted)	1383.31	1365.62	1092.00	882.00	1011.00	47944.01
EPS Growth	30.31%	25.06%	23.81%	-12.76%	-97.89%	9.78%
Free Cash Flow	14,056	16,170	-7,662	7,424	5,695	4,374
Free Cash Flow Per Share	1339.01	1536.95	-763.13	857.83	675.77	25957.86
Gross Margin	48.77%	48.35%	44.25%	44.44%	47.68%	46.55%
Operating Margin	28.83%	28.84%	24.14%	23.20%	27.29%	28.00%
Profit Margin	26.76%	26.80%	23.24%	19.66%	23.68%	24.47%
Free Cash Flow Margin	25.91%	30.17%	-16.24%	19.12%	15.83%	13.25%
EBITDA	16,502	16,302	12,115	9,624	10,396	9,728
EBITDA Margin	30.41%	30.41%	25.68%	24.78%	28.89%	29.47%
D&A For EBITDA	859.96	845.08	727.06	614.18	576.25	484.91
EBIT	15,642	15,457	11,388	9,009	9,820	9,243
EBIT Margin	28.83%	28.84%	24.14%	23.20%	27.29%	28.00%
Effective Tax Rate	18.03%	18.03%	18.75%	14.13%	15.37%	15.22%
Advertising Expenses	-	397.35	408.14	410.82	177.08	132.25

Source: S&P Global Market Intelligence. Standard template. Financial Sources.